I got my PhD in Computer Science from NYU, where I worked on speeding up machine learning algorithms by compiling them to run on graphics cards. After grad school I switched over to computational cancer immunotherapy research at the Icahn School of Medicine at Mount Sinai. After spending a few years getting up to speed on immunology and oncology, I helped start and run three personalized cancer vaccine trials at Mount Sinai before coming to UNC last month. For the past month I have been applying the rapid design principles of personalized cancer vaccines to make a peptide vaccine against SARS-CoV-2. I’m collaborating with my former co-workers at Mount Sinai to open a trial there in the next few months. I’m also collaborating heavily with Ben Vincent’s lab at UNC, which is also working on vaccine antigen selection for SARS-CoV-2 and will be doing some preclinical experiments to help validate vaccine candidates.
Alex Rubinsteyn in UNC Genetics News
July 16, 2020
Alexander Rubinsteyn, PhD Receives Career Development Award from AACR
Dr. Alexander Rubinsteyn (Assistant Professor, Genetics) was awarded a Novocure Career Development Award from the American Association for Cancer Research (AACR) for his project titled “Impact of Tumor Treating Fields on Neoantigen Burden and T Cell Function”.
June 29, 2020
Department of Genetics Publications for June 14-27, 2020
Department of Genetics faculty, postdocs, students and collaborators published nine papers during June 14-27, 2020.
April 9, 2020
Department of Genetics Welcomes Drs. Christoph Rau and Alex Rubinsteyn
Christoph Rau, PhD and Alex Rubinsteyn, PhD joined the Department of Genetics/Computational Medicine Program as Assistant Professors on the tenure track, effective March 1, 2020.